Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.
Politique ou Programme
Affaires autochtones, Santé
Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Politique ou Programme
Développement économique, Emploi et formation, Santé, Industrie, Propriété intellectuelle, Recherche et développement, Sciences et technologies
Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector
Politique ou Programme
Santé, Industrie, Propriété intellectuelle, Commerce international, Recherche et développement, Sciences et technologies
Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations
Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.
Règlement, Proposition législative, Projet de loi ou résolution
Affaires autochtones, Santé, Immigration, Industrie, Recherche et développement, Sciences et technologies
Policy and Programs
Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.